Cargando…
A 15-Gene-Based Risk Signature for Predicting Overall Survival in SCLC Patients Who Have Undergone Surgical Resection
SIMPLE SUMMARY: Small cell lung cancer (SCLC) is a high-grade neuroendocrine carcinoma with a poor prognosis, accounting for approximately 15% of lung cancer cases. Acquired resistance to standard chemotherapy is quite common in SCLC patients, and the survival benefit of surgery and the selection of...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649828/ https://www.ncbi.nlm.nih.gov/pubmed/37958393 http://dx.doi.org/10.3390/cancers15215219 |